RdRp can be a potential therapeutic target to control the infection caused by SARS CoV2 as its human homolog of this nsp12 has not reported [ 6 ] therefore, therapeutic against nsp12 may be significant to control the COVID-19.
← all excerpts
Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus.
1
—
—